156 related articles for article (PubMed ID: 25054142)
1. A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
Saeedi M; Ebrahim-Habibi A; Haghighi A; Zarrabi F; Amoli MM; Robati RM
Biomed Res Int; 2014; 2014():653724. PubMed ID: 25054142
[TBL] [Abstract][Full Text] [Related]
2. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis.
Tanaka A; Arita K; Lai-Cheong JE; Palisson F; Hide M; McGrath JA
Br J Dermatol; 2009 Dec; 161(6):1217-24. PubMed ID: 19663869
[TBL] [Abstract][Full Text] [Related]
3. A new c.1845A→T of oncostatin M receptor-β mutation and slightly enhanced oncostatin M receptor-β expression in a Chinese family with primary localized cutaneous amyloidosis.
Wang WH; Li LF; Huang ES; Zhang Q; Sun TT; Song QH; Xu ML; Chen XR
Eur J Dermatol; 2012; 22(1):29-33. PubMed ID: 22062952
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis.
Arita K; South AP; Hans-Filho G; Sakuma TH; Lai-Cheong J; Clements S; Odashiro M; Odashiro DN; Hans-Neto G; Hans NR; Holder MV; Bhogal BS; Hartshorne ST; Akiyama M; Shimizu H; McGrath JA
Am J Hum Genet; 2008 Jan; 82(1):73-80. PubMed ID: 18179886
[TBL] [Abstract][Full Text] [Related]
5. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis.
Lin MW; Lee DD; Liu TT; Lin YF; Chen SY; Huang CC; Weng HY; Liu YF; Tanaka A; Arita K; Lai-Cheong J; Palisson F; Chang YT; Wong CK; Matsuura I; McGrath JA; Tsai SF
Eur J Hum Genet; 2010 Jan; 18(1):26-32. PubMed ID: 19690585
[TBL] [Abstract][Full Text] [Related]
6. AHNAK, regulated by the OSM/OSMR signaling, involved in the development of primary localized cutaneous amyloidosis.
Liu H; Qiu B; Yang H; Zheng W; Luo Y; Zhong Y; Lu P; Chen J; Luo Y; Liu J; Yang B
J Dermatol Sci; 2023 May; 110(2):53-60. PubMed ID: 37100691
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis.
Lu P; Wu FF; Rong ZL; Fang C; Deng CC; Bin LH; Yang B
Clin Exp Dermatol; 2019 Jun; 44(4):e110-e117. PubMed ID: 30734345
[TBL] [Abstract][Full Text] [Related]
8. The molecular skin pathology of familial primary localized cutaneous amyloidosis.
Tanaka A; Lai-Cheong JE; van den Akker PC; Nagy N; Millington G; Diercks GF; van Voorst Vader PC; Clements SE; Almaani N; Techanukul T; Hide M; South AP; McGrath JA
Exp Dermatol; 2010 May; 19(5):416-23. PubMed ID: 20507362
[TBL] [Abstract][Full Text] [Related]
9. [Identification of pathogenic mutations in two Chinese families affected with primary localized cutaneous amyloidosis].
Mao B; Yao X; Wang Z; Zhao X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):9-13. PubMed ID: 29419851
[TBL] [Abstract][Full Text] [Related]
10. A novel OSMR mutation in familial primary localized cutaneous amyloidosis in a Japanese family.
Arita K; Abe R; Baba K; McGrath JA; Akiyama M; Shimizu H
J Dermatol Sci; 2009 Jul; 55(1):64-5. PubMed ID: 19375894
[No Abstract] [Full Text] [Related]
11. Familial primary localized cutaneous amyloidosis in Brazil.
Sakuma TH; Hans-Filho G; Arita K; Odashiro M; Odashiro DN; Hans NR; Hans-Neto G; McGrath JA
Arch Dermatol; 2009 Jun; 145(6):695-9. PubMed ID: 19528426
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS and immuno-electron subtyping combined with genetics show that OSMR mutations cause amyloid deposition of keratins 5/14 in familial primary localized cutaneous amyloidosis.
Bourguiba R; Bachmeyer C; Moguelet P; Kaaki S; Ory C; Touchard G; Cattan E; Georgin-Lavialle S; Colombat M; Valleix S
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e66-e68. PubMed ID: 34459039
[No Abstract] [Full Text] [Related]
13. OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients.
Liu J; Chen J; Zhong Y; Yu X; Lu P; Feng J; Zhang X; Ma S; Yang C; Yang B; Rong Z
Protein Cell; 2021 Aug; 12(8):653-661. PubMed ID: 33502684
[No Abstract] [Full Text] [Related]
14. Familial primary localized cutaneous amyloidosis with an oncostatin M receptor-β mutation, Pro694Leu.
Schreml S; Weber BH; Schröder J; Siegmund H; Schaller J; Vogt T; Landthaler M; Schönbuchner I; Röcken C; Babilas P
Clin Exp Dermatol; 2013 Dec; 38(8):932-5. PubMed ID: 23692662
[No Abstract] [Full Text] [Related]
15. Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMR.
Wali A; Liu L; Takeichi T; Jelani M; Rahman OU; Heng YK; Thng S; Lee J; Akiyama M; McGrath JA; Betz RC
Acta Derm Venereol; 2015 Nov; 95(8):1005-7. PubMed ID: 25792357
[No Abstract] [Full Text] [Related]
16. Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis.
Babilas P; Fiebig BS; Aslanidis C; Hansen J; Röcken C; Schroeder J; Schmitz G; Weber BH; Landthaler M; Vogt T
Br J Dermatol; 2009 Oct; 161(4):944-7. PubMed ID: 19466957
[No Abstract] [Full Text] [Related]
17. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
Qi XP; Zhao JQ; Chen ZG; Cao JL; Du J; Liu NF; Li F; Sheng M; Fu E; Guo J; Jia H; Zhang YM; Ma JM
Oncotarget; 2015 Oct; 6(32):33993-4003. PubMed ID: 26356818
[TBL] [Abstract][Full Text] [Related]
18. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
[TBL] [Abstract][Full Text] [Related]
19. [Oncostatin M receptor beta mutations in familial primary localised cutaneous amyloidosis].
Dereure O
Ann Dermatol Venereol; 2008 Oct; 135(10):718-9. PubMed ID: 18929930
[No Abstract] [Full Text] [Related]
20. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
